Tuesday, May 17, 2022
Home Tags Rare Diseases

Rare Diseases Related News

Improving rare disease treatment and care

Improving rare disease treatment and care

With no cure available for the majority of rare diseases, HEQ spoke to Dr David A. Pearce from the International Rare Diseases Research Consortium...
Potential drug target for bone marrow cancer

Potential drug target for bone marrow cancer

New research finds patients with a rare type of bone marrow cancer have distinctive epigenetic changes that can activate harmful genes and cause cancer...
Creutzfeldt-Jakob disease

First-ever Creutzfeldt-Jakob disease treatment shows encouraging results

Early study results have highlighted the promising performance of the world’s first treatment for Creutzfeldt-Jakob disease, potentially a landmark step toward treating the deadly...
rare diseases

Working towards a new framework for rare diseases

Health Europa Quarterly speaks with EURORDIS Public Health Policy Director Anna Kole about the current landscape of rare diseases in Europe. The European Organisation for...
Pompe Support Network: living with Pompe disease

Pompe Support Network: living with Pompe disease

HEQ speaks with Allan Muir, Chair of the Board of Trustees at the UK’s Pompe Support Network, about the burden and treatment of Pompe...
Glycogen storage disease

Discussing glycogen storage disease and patient support

AGSD-UK Specialist Care Advisor Jane Lewthwaite speaks to HEQ about the importance of community and advocacy for patients living with glycogen storage disease. The Association...
Hope for rare disease patients: an approach to funding gene therapy

Hope for rare disease patients: an approach to funding gene therapy

Roger Johansson, Vice President and General Manager – Northern Europe with the global biopharmaceutical company PTC Therapeutics, discusses the need to establish an environment...
AOP Orphan: a European pioneer in the field of rare and complex diseases

AOP Orphan: a European pioneer in the field of rare and complex diseases

AOP Orphan optimises the patient experience with integrated therapy solutions combining drugs, medical devices, and empathic care. Austria-based company AOP Orphan Pharmaceuticals AG has been...
Medicine recieves positive opinion for hereditary angioedema patients

Positive opinion for hereditary angioedema medicine for use in patients over 12

The Committee for Medicinal Products for Human Use (CHMP) has recommended the medicine berotralstat for the routine prophylaxis of hereditary angioedema in patients aged...
Innovation in rare diseases: improving patient care for blood cancer

Innovation in rare diseases: improving patient care for blood cancer

AOP Orphan Pharmaceuticals AG is an international pharmaceutical company focusing on rare and special diseases. The company has developed an innovative pen for the...
UK forms new strategy to improve rare disease diagnosis and treatment

UK forms new strategy to improve rare disease diagnosis and treatment

The UK has created a new framework to accelerate the diagnosis of rare diseases, as well as improving treatment and raising awareness. More than 3.5...
Calls for urgent reforms to improve care for rare disease patients

Calls for urgent reforms to improve care for rare disease patients

Organisations are calling on the UK Government and the NHS to implement urgent reforms in order to improve care for patients in the UK...
No deal Brexit could be detrimental for UK rare disease patients

No deal Brexit could be detrimental for UK rare disease patients

Experts have issued a warning that a no deal Brexit could have a hugely detrimental impact on patients in the UK living with a...
Austrian MPS Society’s Therapy Week

Austrian MPS Society’s Therapy Week

Mucopolysaccharidosis are a group of rare, inherited, and incurable diseases, and MPS Society Austria aims to help people and families living with these diseases...
Non-hereditary mutation acts as natural gene therapy for GATA2 deficiency

Non-hereditary mutation acts as natural gene therapy for GATA2 deficiency

Scientists have identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other...
Early access to medicine for hereditary angioedema patients

Early access to medicine for hereditary angioedema patients

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive scientific opinion to the medicine berotralstat for hereditary angioedema patients through...
Is CRISPR gene therapy for rare Angelman Syndrome on the horizon?

Is CRISPR gene therapy for rare Angelman Syndrome on the horizon?

For the first time, scientists have shown how gene editing techniques could be used as therapy for the rare neurodevelopmental disorder – Angelman syndrome. Babies...
New study links 28 genes to rare developmental disorders

New study links 28 genes to rare developmental disorders

A new study has linked 28 genes to rare developmental disorders and has estimated another 1,000 genes linked to these disorders are yet to...
Supporting patients and families with Mucopolysaccharidosis

Supporting patients and families with Mucopolysaccharidosis

Founded in 1985, MPS Austria supports children with Mucopolysaccharidosis and other similar Lysosomal diseases, and their families, by helping to increase quality of life. MPS...
Study shows metyrapone effective for treating rare Cushing’s Syndrome

Study shows metyrapone effective for treating rare Cushing’s Syndrome

The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest